Cancer Research Cancer Medicine 8  Sign up for Cancer Research eTOC's
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Li, K.
Right arrow Articles by Seu, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Li, K.
Right arrow Articles by Seu, P.
[Cancer Research 63, 3593-3597, July 1, 2003]
© 2003 American Association for Cancer Research


Experimental Therapeutics

Use of RNA Interference to Target Cyclin E-overexpressing Hepatocellular Carcinoma1

Kaiyi Li2, Shiaw-Yih Lin, F. Charles Brunicardi and Philip Seu2

Departments of Surgery [K. L., F. C. B., P. S.] and Biochemistry [S. Y-L.], Baylor College of Medicine, Houston, Texas 77030, and The Methodist Hospital, Houston, Texas 77030

RNA interference is the process by which double-stranded RNA directs sequence-specific degradation of mRNA. It has recently been shown that RNA interference can be triggered by 21-nucleotide duplexes of small interfering RNAs (siRNAs) in both cultured mammalian cells and adult mice. We hypothesize that siRNA can be used to specifically target oncogene overexpression in a therapeutic manner. Here, we show that overexpression of the oncogene cyclin E can be suppressed by up to 90% in hepatocellular carcinoma (HCC) cell lines by siRNA targeted on the coding region of cyclin E. We also find that depletion of cyclin E in this manner promotes apoptosis of HCC cells and blocks cell proliferation. Finally, we show that the siRNA oligos inhibits HCC tumor growth in nude mice. Thus, this study demonstrates the therapeutic potential of siRNA on the treatment of HCC by targeting overexpressed oncogenes such as cyclin E. Our results also indicate that cyclin E, which is overexpressed in 70% of HCCs, may serve as a novel therapeutic target.




This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
Y. Zou, J. Mi, J. Cui, D. Lu, X. Zhang, C. Guo, G. Gao, Q. Liu, B. Chen, C. Shao, et al.
Characterization of Nuclear Localization Signal in the N Terminus of CUL4B and Its Essential Role in Cyclin E Degradation and Cell Cycle Progression
J. Biol. Chem., November 27, 2009; 284(48): 33320 - 33332.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
M. Kikuchi, C. Zhu, T. Senoo, Y. Obara, and N. C. Joyce
p27kip1 siRNA Induces Proliferation in Corneal Endothelial Cells from Young but Not Older Donors
Invest. Ophthalmol. Vis. Sci., November 1, 2006; 47(11): 4803 - 4809.
[Abstract] [Full Text] [PDF]


Home page
Nucleic Acids ResHome page
N. Yang, L. Zhang, and H. H. Kazazian Jr
L1 retrotransposon-mediated stable gene silencing
Nucleic Acids Res., March 30, 2005; 33(6): e57 - e57.
[Abstract] [Full Text] [PDF]


Home page
Molecular Cancer TherapeuticsHome page
A. Salvi, B. Arici, G. De Petro, and S. Barlati
Small interfering RNA urokinase silencing inhibits invasion and migration of human hepatocellular carcinoma cells
Mol. Cancer Ther., June 1, 2004; 3(6): 671 - 678.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2003 by the American Association for Cancer Research.